| Enriched cancer pathway | Genes under regulation | P value |
|---|
| Long.term depression |
5 genes: GNAO1, GNAQ, IGF1, IGF1R, PRKG1
|
0.0001359 |
| Vascular smooth muscle contraction |
5 genes: EDNRA, GNAQ, PPP1R12B, PPP1CB, PRKG1
|
0.00139 |
| Ras signaling pathway |
6 genes: FGF2, BDNF, IGF1, ANGPT2, IGF1R, RASAL2
|
0.006625 |
| Calcium signaling pathway |
5 genes: EDNRA, GNAL, GNAQ, RYR2, SLC8A1
|
0.008437 |
| Axon guidance |
4 genes: EPHA3, PLXNA2, SLIT3, UNC5C
|
0.01357 |
| Glycosaminoglycan biosynthesis . heparan sulfate |
2 genes: EXT1, NDST1
|
0.01436 |
| Mucin type O.Glycan biosynthesis |
2 genes: GALNT10, ST3GAL1
|
0.01887 |
| Hippo signaling pathway |
4 genes: FRMD6, PPP1CB, SERPINE1, BMPR2
|
0.02369 |
| Purine metabolism |
4 genes: NT5E, PDE4D, PDE5A, ENTPD1
|
0.02785 |
| Oocyte meiosis |
3 genes: IGF1, IGF1R, PPP1CB
|
0.04685 |